UK markets closed

Invitae Corporation (0JDB.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
28.10-0.36 (-1.26%)
At close: 6:38PM BST
Sign in to post a message.
  • G
    Greg-1
    "The company says at least one Volpara software product is used with over 32 per cent of women who attend a breast cancer screening each year in the United States. "

    https://themarketherald.com.au/volpara-health-technologies-asxvht-teams-up-with-invitae-2021-07-19/

    More evidence that $NVTA is executing its vision. This illustrates the difference between $NVTA and traditional diagnostic companies. $NVTA is a genetics testing platform that other healthcare technology services can seamlessly integrate into their care flow. This is a first mover takes most market. How many genetics testing platforms do you think 3rd parties want to integrate with? This is why aggressive investment is critical for $NVTA to be the de-facto genetics testing platform that all other services integrate with.

    Buy now. You won't see these prices again. You've been warned.
  • P
    Peter
    This stock is really a very long term play and not for people who want fast returns. I think accumulating slowly on the big dips will pay off in 5 to 10 years.
  • C
    Charles
    Anything under $30 is a gift imho
  • L
    Listener2307
    Lots of "long term" comments. But if you do not believe it is going to go up immediately, why buy it at all?
  • M
    MARINE CP 45
    Be patient - will drop to around 27 before aug earnings Anything can happen then - further slide or up tp 35
    If u can't hold 1-2 yrs don't buy
  • G
    Greg-1
    Any insight into earnings this quarter? Is there going to be good/improving news and a jump?
  • A
    American
    From the start of 2017 to now the shares outstanding has gone from 33M to 200M.
    Sorry fellas you are stuck with this one. CEO uses you as a cash register.
  • B
    Brett
    Apple building new facility in Research Triangle area.
    Invitae building new facility in Research Triangle area.

    Apple has/is creating a foothold in the healthcare Industry.

    H'mmm....
  • I
    Ivy
    Hmmm ... this is so cheap now. Take advantage of dip or hold?
  • m
    michael
    This is destined for Andromeda
  • A
    Anthony
    6th day of losses in a row today was in anticipation of the fed tightening green tomorrow
  • G
    Greg-1
    For a company with $1T market cap potential (even in the distant future), the current price is incredibly cheap. Buy now.
  • M
    M
    Just as an FYI, NVTA was included in a document sent earlier this week by the Motley Fool to subscribers which reported three stocks that they think are up for a 10x gain. The document is named "Buy the dip". I think they don't expect it to go up that much quickly, but over a few years they expect great gains. So after looking at some of the stocks they suggested I decided to buy some NVTA. Hope this helps other investors.
  • K
    Kojak
    We will see 60s again this year
  • V
    VanillaBean
    Intellia pumping biotech!
  • F
    Floridafun
    June 03, 2021 Goldman Sachs Initiates Coverage On Invitae with Neutral Rating, Announces Price Target of $33
  • G
    Gail
    This stock is like a roller coaster, volatility is the name of the game, but I like watching it bounce around. I'm in it long term.
  • V
    VanillaBean
    Arkg has been loading up on QSI. It is protein sequencing. 1.5B mc.
  • f
    farhad
    When is the next earnings? Thanks